Telehealth Company Hims Expands Into Testosterone Replacement Therapy
Telehealth giant Hims plans to offer testosterone replacement therapy, marking its first major entry into prescribing controlled substances. This expansion allows the company to reach a broader demographic seeking hormone treatments, raising important questions about the medical oversight and safety protocols surrounding widespread digital prescriptions for controlled hormones.
Source: Wired